These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 8107239)

  • 1. Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein.
    Rein A; Mirro J; Haynes JG; Ernst SM; Nagashima K
    J Virol; 1994 Mar; 68(3):1773-81. PubMed ID: 8107239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. pH-independent murine leukemia virus ecotropic envelope-mediated cell fusion: implications for the role of the R peptide and p12E TM in viral entry.
    Ragheb JA; Anderson WF
    J Virol; 1994 May; 68(5):3220-31. PubMed ID: 8151784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations at the C-terminus of the simian immunodeficiency virus envelope glycoprotein affect gp120-gp41 stability on virions.
    Affranchino JL; González SA
    Virology; 2006 Mar; 347(1):217-25. PubMed ID: 16380144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for cooperation between murine leukemia virus Env molecules in mixed oligomers.
    Rein A; Yang C; Haynes JA; Mirro J; Compans RW
    J Virol; 1998 Apr; 72(4):3432-5. PubMed ID: 9525676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cleavage of the murine leukemia virus transmembrane env protein by human immunodeficiency virus type 1 protease: transdominant inhibition by matrix mutations.
    Kiernan RE; Freed EO
    J Virol; 1998 Dec; 72(12):9621-7. PubMed ID: 9811695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of R peptide of murine leukemia virus envelope glycoproteins in syncytium formation and entry.
    Kubo Y; Tominaga C; Yoshii H; Kamiyama H; Mitani C; Amanuma H; Yamamoto N
    Arch Virol; 2007; 152(12):2169-82. PubMed ID: 17851730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palmitoylation of the intracytoplasmic R peptide of the transmembrane envelope protein in Moloney murine leukemia virus.
    Olsen KE; Andersen KB
    J Virol; 1999 Nov; 73(11):8975-81. PubMed ID: 10516003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure To cleave murine leukemia virus envelope protein does not preclude its incorporation in virions and productive virus-receptor interaction.
    Zavorotinskaya T; Albritton LM
    J Virol; 1999 Jul; 73(7):5621-9. PubMed ID: 10364311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of mutations within the cytoplasmic domain of the Moloney murine leukemia virus transmembrane protein.
    Thomas A; Gray KD; Roth MJ
    Virology; 1997 Jan; 227(2):305-13. PubMed ID: 9018129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uncoupled expression of Moloney murine leukemia virus envelope polypeptides SU and TM: a functional analysis of the role of TM domains in viral entry.
    Ragheb JA; Anderson WF
    J Virol; 1994 May; 68(5):3207-19. PubMed ID: 7512161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The critical N-linked glycan of murine leukemia virus envelope protein promotes both folding of the C-terminal domains of the precursor polyprotein and stability of the postcleavage envelope complex.
    Li Z; Pinter A; Kayman SC
    J Virol; 1997 Sep; 71(9):7012-9. PubMed ID: 9261431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational analysis of the R peptide cleavage site of Moloney murine leukaemia virus envelope protein.
    Kubo Y; Amanuma H
    J Gen Virol; 2003 Aug; 84(Pt 8):2253-2257. PubMed ID: 12867658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basis for receptor specificity of nonecotropic murine leukemia virus surface glycoprotein gp70SU.
    Ott D; Rein A
    J Virol; 1992 Aug; 66(8):4632-8. PubMed ID: 1321266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membrane-proximal cytoplasmic domain of Moloney murine leukemia virus envelope tail facilitates fusion.
    Rozenberg-Adler Y; Conner J; Aguilar-Carreno H; Chakraborti S; Dimitrov DS; Anderson WF
    Exp Mol Pathol; 2008 Feb; 84(1):18-30. PubMed ID: 18222422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of cell cytoskeleton in Mo-MuLV env transport and processing: implications in ts1 neuropathology.
    Soong MM; Tompkins WA
    Exp Mol Pathol; 1987 Jun; 46(3):294-311. PubMed ID: 2439368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations affecting the cytoplasmic domain of the Moloney murine leukemia virus envelope protein: rapid reversion during replication.
    Granowitz C; Berkowitz RD; Goff SP
    Virus Res; 1996 Mar; 41(1):25-42. PubMed ID: 8725100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of mutations in the envelope gene of Moloney murine leukemia virus: separation of infectivity from superinfection resistance.
    Granowitz C; Colicelli J; Goff SP
    Virology; 1991 Aug; 183(2):545-54. PubMed ID: 1853560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in the cytoplasmic tail of murine leukemia virus envelope protein suppress fusion inhibition by R peptide.
    Li M; Yang C; Compans RW
    J Virol; 2001 Mar; 75(5):2337-44. PubMed ID: 11160737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell fusion induced by the murine leukemia virus envelope glycoprotein.
    Jones JS; Risser R
    J Virol; 1993 Jan; 67(1):67-74. PubMed ID: 8416389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A deletion mutation in the 5' part of the pol gene of Moloney murine leukemia virus blocks proteolytic processing of the gag and pol polyproteins.
    Crawford S; Goff SP
    J Virol; 1985 Mar; 53(3):899-907. PubMed ID: 3882995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.